NNNN Anbio Biotechnology
Stock Price & Overview

$47.11-3.72 (-7.32%)4:00 PM 07/29/25
NASDAQ | $USD | Post-Market: $46.40 -0.71 (-1.51%) 7:39 PM

NNNN Stock Price

EPS
PE
Div Rate
Yield
Short Interest
Market Cap
Volume
Prev. Close
Expand For Key Data »

Quant Ranking

NNNN Analysis

NNNN News

Latest Headlines

Seasonality

Displays mean and median monthly returns for NNNN in order to identify seasonal patterns.
YearJanFebMarAprMayJunJulAugSepOctNovDec

Ratings Summary

People Also Follow

Similar to NNNN

ETFs Holding NNNN

NNNN Company Profile

Anbio Biotechnology logo
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.
Sector
Health Care
Industry
Biotechnology
Employees
27
Founded
2021
Address
  • Wilhelm Gutbrod Str 21B
  • Frankfurt am Main, 60437
  • Germany
Phone Number
49 16 0962 47281
Website
www.anbio.com
Hide

NNNN Revenue

More On Revenue »

Earnings Revisions

Valuation

Growth

Profitability

Momentum

Capital Structure

Dividends

NNNN does not currently pay a dividend.

NNNN Ownership

NNNN Peers

Risk

Technicals

NNNN SEC Filings

Press Releases

NNNN Income Statement

NNNN Balance Sheet

NNNN Cash Flow Statement

NNNN Long Term Solvency

Anbio Biotechnology (NNNN) Frequently Asked Questions